8477EGP
- Active ingredient
- erenumab
- Strength
- 70mg/ml
- Form
- pen
- Manufacturer
- novartis
- Route
- injection
Uses
Used for preventive treatment of migraine in adults.
Do not use if
Serious hypersensitivity to erenumab or any excipient.
Side effects
Injection-site reactions, constipation, hypertension, and hypersensitivity reactions may occur.
Warnings
Monitor for severe constipation, hypertension, and allergic reactions.
How it works
Monoclonal antibody that blocks the CGRP receptor involved in migraine pathophysiology.
Storage
Store refrigerated at 2–8°C in the original carton. Do not freeze.
